[S02DA03, antipyrine, Antipyrine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01GA01, streptomycin, Fenofibric acid may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sulfamethoxazole is combined with Fenofibric acid.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glibornuride.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Fenofibric acid.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Dabigatran etexilate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03BA03, testosterone, Testosterone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S03AA02, tetracycline, Tetracycline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05AL03, tiapride, Tiapride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AC05, ticlopidine, Ticlopidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01ED01, timolol, Timolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA12, tobramycin, Fenofibric acid may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Tolbutamide.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Fenofibric acid.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fenofibric acid.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A03AA05, trimebutine, Trimebutine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Fenofibric acid.]
[R03DX07, roflumilast, Roflumilast may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R02AA14, oxyquinoline, Oxyquinoline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA28, vancomycin, Fenofibric acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AF01, rivaroxaban, Rivaroxaban may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C08DA01, verapamil, Verapamil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX09, viloxazine, Viloxazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Fenofibric acid.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AA03, warfarin, Fenofibric acid may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Fenofibric acid.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Indinavir is combined with Fenofibric acid.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Fenofibric acid.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Fenofibric acid.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Ruxolitinib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BD07, tolterodine, Tolterodine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fenofibric acid.]
[A08AA11, lorcaserin, Lorcaserin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BD12, mirabegron, Mirabegron may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02BB04, enzalutamide, Enzalutamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N04BD02, rasagiline, Rasagiline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Fenofibric acid.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Fenofibric acid.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BH04, alogliptin, Alogliptin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, Glycerol phenylbutyrate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Pomalidomide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin detemir.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Fenofibric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX28, levomilnacipran, Levomilnacipran may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A05AA03, cholic acid, The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Fenofibric acid.]
[C02KX04, macitentan, Macitentan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX26, vortioxetine, Vortioxetine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CH03, tasimelteon, Tasimelteon may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AA32, apremilast, Apremilast may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02BG02, formestane, Formestane may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Fenofibric acid.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AB02, bezafibrate, The risk or severity of adverse effects can be increased when Bezafibrate is combined with Fenofibric acid.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Acenocoumarol.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S03AA06, gentamicin, Fenofibric acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Dicoumarol.]
[B01AF03, edoxaban, Edoxaban may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BE01, acetaminophen, Acetaminophen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin degludec.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Acipimox is combined with Fenofibric acid.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trabectedin is combined with Fenofibric acid.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Fenofibric acid.]
[L01XG03, ixazomib, Ixazomib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Acetohexamide.]
[M04AB05, lesinurad, Lesinurad may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BA08, bromazepam, Bromazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Almasilate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A05AA04, obeticholic acid, The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Fenofibric acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01XX27, arsenic trioxide, Arsenic trioxide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A06AH05, naldemedine, Naldemedine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Deutetrabenazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P01CA02, benznidazole, Benznidazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07XX13, valbenazine, Valbenazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Fenofibric acid.]
[J01MA23, delafloxacin, Delafloxacin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BC06, capecitabine, Capecitabine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Budesonide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Captopril is combined with Fenofibric acid.]
[L02BB05, apalutamide, Apalutamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AF01, carbamazepine, Fenofibric acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Fenofibric acid.]
[L04AA37, baricitinib, Baricitinib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01GB14, plazomicin, Fenofibric acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AX17, stiripentol, Stiripentol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Carbutamide.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A06AX05, prucalopride, Prucalopride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AC23, cilostazol, Cilostazol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AB08, ciprofibrate, The risk or severity of adverse effects can be increased when Ciprofibrate is combined with Fenofibric acid.]
[N06BA14, solriamfetol, Fenofibric acid may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N05BA09, clobazam, Clobazam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ubidecarenone is combined with Fenofibric acid.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Fenofibric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07XX11, pitolisant, Pitolisant may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin pork.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Fenofibric acid.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M09AX08, golodirsen, Fenofibric acid may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R02AA03, dichlorobenzyl alcohol, Dichlorobenzyl alcohol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03DB08, dienogest, Dienogest may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C08CA16, clevidipine, Clevidipine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Fenofibric acid.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Fenofibric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA03, choline salicylate, Fenofibric acid may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of adverse effects can be increased when Etofibrate is combined with Fenofibric acid.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CH02, indigo carmine, Indigotindisulfonic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Fenofibric acid.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Fenofibric acid.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A05AA02, ursodiol, The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibric acid.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fusidic acid is combined with Fenofibric acid.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin human.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cimetidine is combined with Fenofibric acid.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fenofibric acid.]
[L01XA01, cisplatin, Fenofibric acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Gliquidone.]
[C10AB01, clofibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Fenofibric acid.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AA04, clomipramine, Clomipramine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, Clozapine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01GB12, arbekacin, Fenofibric acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Colchicine is combined with Fenofibric acid.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Fenofibric acid resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XB01, colistin, Fenofibric acid may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leflunomide is combined with Fenofibric acid.]
[A04AA03, tropisetron, Tropisetron may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BX03, nateglinide, Nateglinide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin glargine.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BA10, ketazolam, Ketazolam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Fenofibric acid.]
[N07BC04, lofexidine, Lofexidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Magnesium carbonate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mebeverine is combined with Fenofibric acid.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Melperone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01XA18, cyclosporine, The risk or severity of renal failure can be increased when Cyclosporine is combined with Fenofibric acid.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03XA02, conivaptan, Conivaptan may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Fenofibric acid.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX06, nefazodone, Nefazodone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01DX16, nicorandil, Nicorandil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AA01, desipramine, Desipramine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Dexamethasone is combined with Fenofibric acid.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BA01, diazepam, Diazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C08CA03, isradipine, Isradipine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[D07XC04, diflucortolone, Difluocortolone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01AA05, digoxin, Fenofibric acid may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, The serum concentration of Ezetimibe can be increased when it is combined with Fenofibric acid.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AE08, atazanavir, Atazanavir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, Dimethyl sulfoxide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R06AE09, levocetirizine, Levocetirizine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Fenofibric acid.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AA12, doxepin, Doxepin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Simvastatin.]
[A12CA02, sodium sulfate, Sodium sulfate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Fenofibric acid.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Emetine is combined with Fenofibric acid.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tianeptine is combined with Fenofibric acid.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Fenofibric acid.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AX11, topiramate, Topiramate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin glulisine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Iloprost is combined with Fenofibric acid.]
[L03AX05, pidotimod, Pidotimod may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03CA03, estradiol, Estradiol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AA04, fluvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AC06, meloxicam, Meloxicam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AD02, tacrolimus, Tacrolimus may increase the nephrotoxic activities of Fenofibric acid.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Fenofibric acid.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX12, bupropion, Bupropion may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AB08, fluvoxamine, Fluvoxamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibric acid.]
[C10AA03, pravastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[D11AX24, deoxycholic acid, The therapeutic efficacy of Deoxycholic acid can be decreased when used in combination with Fenofibric acid.]
[B05AA05, dextran, Dextran may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Fenofibric acid.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J02AC01, fluconazole, Fluconazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Fenofibric acid.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BC03, tegafur, Tegafur may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fenofibric acid.]
[C10AB04, gemfibrozil, The risk or severity of adverse effects can be increased when Gemfibrozil is combined with Fenofibric acid.]
[J01XA03, telavancin, Telavancin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BB01, glyburide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glyburide.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Glipizide.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01EX02, sorafenib, Sorafenib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Fluindione.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05AD01, haloperidol, Haloperidol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05AH04, quetiapine, Quetiapine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin aspart.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C02DB02, hydralazine, Hydralazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Fenofibric acid may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BD06, propiverine, Propiverine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Fenofibric acid.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01AA06, ifosfamide, Ifosfamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AA02, imipramine, Imipramine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Paclitaxel is combined with Fenofibric acid.]
[R01AD07, tixocortol, Tixocortol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A11HA07, inositol, Inositol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX17, milnacipran, Milnacipran may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01XA28, varenicline, Varenicline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CH02, ramelteon, Ramelteon may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AA06, cerivastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Cerivastatin.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ipecac is combined with Fenofibric acid.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Fenofibric acid.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isoniazid is combined with Fenofibric acid.]
[J05AX05, inosine pranobex, Inosine pranobex may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Fenofibric acid.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Fenofibric acid.]
[S01AA24, kanamycin, Fenofibric acid may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibric acid.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AC22, prasugrel, Prasugrel may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AA21, amikacin, Fenofibric acid may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AA02, lovastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Lovastatin.]
[B05XA11, magnesium chloride, Magnesium chloride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BA05, pralatrexate, Pralatrexate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Fenofibric acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Paliperidone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07BC02, methadone, Methadone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06BA03, methamphetamine, Metamfetamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Fenofibric acid.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01BA04, pemetrexed, Fenofibric acid may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methotrexate is combined with Fenofibric acid.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Fenofibric acid.]
[V04CG05, methylene blue, Methylene blue may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G03EK01, methyltestosterone, Methyltestosterone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Metoclopramide is combined with Fenofibric acid.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CD01, metyrapone, Metyrapone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BB03, aminopyrine, Aminophenazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CD08, midazolam, Midazolam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Fenofibric acid.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amiodarone is combined with Fenofibric acid.]
[N06AA09, amitriptyline, Amitriptyline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AB05, certolizumab pegol, Certolizumab pegol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Raltegravir is combined with Fenofibric acid.]
[C07AA12, nadolol, Nadolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V03AB15, naloxone, Naloxone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Fenofibric acid.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AX21, duloxetine, Duloxetine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Docetaxel is combined with Fenofibric acid.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Fenofibric acid.]
[S03AA01, neomycin, Fenofibric acid may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Fenofibric acid.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AA23, netilmicin, Fenofibric acid may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, Desvenlafaxine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Fenofibric acid.]
[C08CA05, nifedipine, Nifedipine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Norfloxacin is combined with Fenofibric acid.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ofloxacin is combined with Fenofibric acid.]
[N02AA02, opium, Opium may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J04AB30, capreomycin, Fenofibric acid may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BD11, fesoterodine, Fesoterodine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C07AA23, penbutolol, Penbutolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Fenofibric acid.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CA01, pentobarbital, Pentobarbital may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[L01XX08, pentostatin, Fenofibric acid may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Fenofibric acid is combined with Phenprocoumon.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Phenytoin is combined with Fenofibric acid.]
[S01AE05, levofloxacin, Levofloxacin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Saquinavir is combined with Fenofibric acid.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Fenofibric acid.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ritonavir is combined with Fenofibric acid.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Fenofibric acid is combined with Insulin lispro.]
[C10AA08, pitavastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Pitavastatin.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[M04AB01, probenecid, Probenecid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01BA02, procainamide, Fenofibric acid may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Procarbazine is combined with Fenofibric acid.]
[R06AD02, promethazine, Promethazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Fenofibric acid.]
[C07AA05, propranolol, Propranolol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Fenofibric acid.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[B01AC09, epoprostenol, Epoprostenol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Fenofibric acid.]
[N07XX07, dalfampridine, Dalfampridine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[P02CC01, pyrantel, Pyrantel may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C01BA01, quinidine, Fenofibric acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Fenofibric acid.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[N05CA06, secobarbital, Secobarbital may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[J01GB08, sisomicin, Fenofibric acid may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Fenofibrate.]
[J01GA01, streptomycin, Fenofibrate may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01CG01, sulbactam, Fenofibrate may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, Sulfamethoxazole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M04AB02, sulfinpyrazone, Fenofibrate may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glibornuride.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Fenofibrate.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Fenofibrate.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Fenofibrate.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Fenofibrate may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The metabolism of Fenofibrate can be increased when combined with Testosterone.]
[S03AA02, tetracycline, The metabolism of Fenofibrate can be decreased when combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Fenofibrate.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Fenofibrate.]
[L04AX02, thalidomide, The metabolism of Thalidomide can be decreased when combined with Fenofibrate.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Fenofibrate.]
[P02CA02, thiabendazole, Thiabendazole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Fenofibrate.]
[N05CA19, thiopental, The metabolism of Thiopental can be decreased when combined with Fenofibrate.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Fenofibrate.]
[G04BE06, moxisylyte, Fenofibrate may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Fenofibrate may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Fenofibrate.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Fenofibrate.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01AA12, tobramycin, Fenofibrate may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Tolazamide.]
[V04CA01, tolbutamide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Tolbutamide.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02AX02, tramadol, Tramadol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Fenofibrate.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triamcinolone is combined with Fenofibrate.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Triazolam is combined with Fenofibrate.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Fenofibrate may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Fenofibrate can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Fenofibrate may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[N03AC02, trimethadione, The metabolism of Trimethadione can be decreased when combined with Fenofibrate.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Fenofibrate.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Fenofibrate.]
[J01FA08, troleandomycin, The metabolism of Fenofibrate can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Fenofibrate.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Fenofibrate.]
[L01FX04, ipilimumab, Fenofibrate may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Fenofibrate.]
[R02AA14, oxyquinoline, Fenofibrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Fenofibrate can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Fenofibrate can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Fenofibrate can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Rilpivirine can be decreased when combined with Fenofibrate.]
[S01AA28, vancomycin, Fenofibrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Fenofibrate may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Fenofibrate may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Fenofibrate can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Fenofibrate can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Fenofibrate can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Fenofibrate.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Fenofibrate.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Fenofibrate.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Fenofibrate can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Fenofibrate.]
[S01AA13, fusidic acid, Fusidic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Fenofibrate.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Fenofibrate.]
[J05AE02, indinavir, The metabolism of Fenofibrate can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Fenofibrate.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Fenofibrate.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Fenofibrate.]
[M05BA05, tiludronic acid, Fenofibrate may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Fenofibrate may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Fenofibrate.]
[R03DC01, zafirlukast, The metabolism of Fenofibrate can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Rabeprazole can be decreased when combined with Fenofibrate.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ibandronate is combined with Fenofibrate.]
[N05AE04, ziprasidone, The metabolism of Fenofibrate can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Fenofibrate may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The metabolism of Acetylsalicylic acid can be decreased when combined with Fenofibrate.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Fenofibrate.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Fenofibrate.]
[J01DH04, doripenem, Fenofibrate may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J02AC03, voriconazole, The metabolism of Fenofibrate can be decreased when combined with Voriconazole.]
[S01FA01, atropine, Atropine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Fenofibrate.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Fenofibrate.]
[R07AX02, ivacaftor, The metabolism of Fenofibrate can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Fenofibrate can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Fenofibrate may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AX01, azathioprine, Azathioprine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Fenofibrate.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fenofibrate.]
[A08AA11, lorcaserin, Fenofibrate may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Fenofibrate may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, The metabolism of Fenofibrate can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Fenofibrate can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Fenofibrate can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Fenofibrate.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Fenofibrate.]
[N05CA04, barbital, The metabolism of Fenofibrate can be increased when combined with Barbital.]
[D02BA02, octinoxate, Fenofibrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Fenofibrate can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Fenofibrate may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Fenofibrate.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Fenofibrate.]
[N03AX22, perampanel, The metabolism of Fenofibrate can be increased when combined with Perampanel.]
[V09IX04, fluorodeoxyglucose F18, Fenofibrate may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Fenofibrate.]
[H01CB05, pasireotide, The metabolism of Fenofibrate can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Sildenafil is combined with Fenofibrate.]
[V08CA11, gadofosveset, Fenofibrate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Fenofibrate.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Fenofibrate.]
[A16AX08, teduglutide, Fenofibrate may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Fenofibrate.]
[A10BH04, alogliptin, Fenofibrate may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Fenofibrate can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Fenofibrate.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Fenofibrate.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[M04AB03, benzbromarone, Fenofibrate may decrease the excretion rate of Benzbromarone which could result in a higher serum level.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Fenofibrate.]
[L03AA12, ancestim, Fenofibrate may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, Celecoxib may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C10AC04, colesevelam, Colesevelam can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Fenofibrate.]
[N04AC01, benztropine, Benzatropine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Fenofibrate can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EE01, trametinib, Fenofibrate may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Fenofibrate.]
[V09AX05, florbetapir F-18, Fenofibrate may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Fenofibrate may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Fenofibrate.]
[A10BJ03, lixisenatide, Fenofibrate may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Fenofibrate.]
[C02KX04, macitentan, Fenofibrate may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Fenofibrate.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The metabolism of Fenofibrate can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, Simeprevir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AP08, sofosbuvir, Fenofibrate may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Fenofibrate may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Fenofibrate.]
[A16AA07, metreleptin, The metabolism of Fenofibrate can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Fenofibrate can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Fenofibrate can be increased when combined with Formestane.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Fenofibrate.]
[V03AB34, fomepizole, Fenofibrate may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C10AB02, bezafibrate, The risk or severity of adverse effects can be increased when Fenofibrate is combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Fenofibrate can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Fenofibrate.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Fenofibrate.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Fenofibrate.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Fenofibrate.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Fenofibrate.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Fenofibrate.]
[J01XA05, oritavancin, The metabolism of Fenofibrate can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Fenofibrate.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Fenofibrate.]
[S03AA06, gentamicin, Fenofibrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fenofibrate.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Fenofibrate.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Fenofibrate.]
[B01AF03, edoxaban, Fenofibrate may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Fenofibrate can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Fenofibrate can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Fenofibrate.]
[L01EX08, lenvatinib, Lenvatinib may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Fenofibrate.]
[N02BE01, acetaminophen, The metabolism of Fenofibrate can be increased when combined with Acetaminophen.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Fenofibrate is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Fenofibrate can be increased when combined with Asunaprevir.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Fenofibrate.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin degludec.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Acipimox.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Fenofibrate.]
[V03AB37, idarucizumab, Fenofibrate may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Fenofibrate.]
[J02AC05, isavuconazole, The metabolism of Fenofibrate can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Fenofibrate.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Fenofibrate.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Fenofibrate.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Fenofibrate.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Fenofibrate.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Fenofibrate.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Fenofibrate can be increased when combined with Lesinurad.]
[N05CA05, aprobarbital, The metabolism of Fenofibrate can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Fenofibrate.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Fenofibrate.]
[N05BA08, bromazepam, Fenofibrate may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Fenofibrate may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Fenofibrate.]
[A05AA04, obeticholic acid, The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Fenofibrate.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, Levobupivacaine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Fenofibrate.]
[N05BE01, buspirone, Buspirone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Fenofibrate.]
[L01XX27, arsenic trioxide, Fenofibrate may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Fenofibrate.]
[M02AA03, clofezone, The metabolism of Rabeprazole can be decreased when combined with Fenofibrate.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Fenofibrate.]
[L01XK03, rucaparib, The metabolism of Fenofibrate can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Fenofibrate can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Fenofibrate can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A06AH05, naldemedine, Fenofibrate may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Fenofibrate may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[D05AX03, calcitriol, The metabolism of Fenofibrate can be increased when combined with Calcitriol.]
[P01CA02, benznidazole, Fenofibrate may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Fenofibrate may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Fenofibrate can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Fenofibrate may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Fenofibrate can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Fenofibrate can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Fenofibrate.]
[L04AC14, sarilumab, The metabolism of Fenofibrate can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, Fenofibrate may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[D01AC10, bifonazole, The metabolism of Fenofibrate can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Fenofibrate.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Fenofibrate.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Fenofibrate.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Fenofibrate.]
[L01EF03, abemaciclib, The metabolism of Abemaciclib can be decreased when combined with Fenofibrate.]
[C07AB07, bisoprolol, Bisoprolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Fenofibrate can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, Fenofibrate may decrease the excretion rate of Budesonide which could result in a higher serum level.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Fenofibrate.]
[J05AX18, letermovir, Letermovir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N01BX04, capsaicin, The metabolism of Fenofibrate can be decreased when combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Fenofibrate may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Captopril.]
[L02BB05, apalutamide, The metabolism of Fenofibrate can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Fenofibrate can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Fenofibrate.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Fenofibrate.]
[B02BX09, fostamatinib, The metabolism of Fenofibrate can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Fenofibrate can be decreased when combined with Cannabidiol.]
[L04AA37, baricitinib, Fenofibrate may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01GB14, plazomicin, Fenofibrate may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fenofibrate.]
[L01XX62, ivosidenib, The metabolism of Fenofibrate can be increased when combined with Ivosidenib.]
[A16AX14, migalastat, Fenofibrate may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Fenofibrate can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Fenofibrate can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Fenofibrate.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Fenofibrate.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Carbutamide.]
[D08AE05, chloroxylenol, Fenofibrate may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Fenofibrate.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M03BA02, carisoprodol, The metabolism of Carisoprodol can be decreased when combined with Fenofibrate.]
[L01ED05, lorlatinib, The metabolism of Fenofibrate can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Fenofibrate can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Fenofibrate.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Fenofibrate.]
[A06AX05, prucalopride, Fenofibrate may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Fenofibrate.]
[C10AB08, ciprofibrate, The risk or severity of adverse effects can be increased when Fenofibrate is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Fenofibrate can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Fenofibrate can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Fenofibrate.]
[J01FA09, clarithromycin, The metabolism of Fenofibrate can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Fenofibrate may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Fenofibrate.]
[N05BA09, clobazam, The metabolism of Fenofibrate can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Fenofibrate can be increased when combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Ubidecarenone.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Fenofibrate.]
[L04AB01, etanercept, The metabolism of Fenofibrate can be increased when combined with Etanercept.]
[V03AE02, sevelamer, Sevelamer can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H02AB17, cortivazol, The metabolism of Fenofibrate can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Fenofibrate.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Fenofibrate.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Fenofibrate.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Fenofibrate.]
[N07XX11, pitolisant, The serum concentration of Fenofibrate can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Fenofibrate.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Fenofibrate.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Fenofibrate.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE03, insulin, regular, pork, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin pork.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Fenofibrate.]
[J01DB01, cephalexin, The metabolism of Fenofibrate can be decreased when combined with Cephalexin.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DB09, cephradine, The metabolism of Fenofibrate can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Fenofibrate can be increased when combined with Deflazacort.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Fenofibrate.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Fenofibrate.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Fenofibrate.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Fenofibrate.]
[N03AX25, cenobamate, The serum concentration of Fenofibrate can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M09AX08, golodirsen, Fenofibrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Fenofibrate may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Fenofibrate.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Fenofibrate.]
[J05AB16, remdesivir, The metabolism of Fenofibrate can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Fenofibrate can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Fenofibrate can be decreased when combined with Amprenavir.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Fenofibrate.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Fenofibrate.]
[R02AA03, dichlorobenzyl alcohol, Fenofibrate may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Fenofibrate may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Fenofibrate.]
[M01AH02, rofecoxib, The metabolism of Fenofibrate can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Fenofibrate can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Fenofibrate can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Fenofibrate.]
[J01FA13, dirithromycin, The metabolism of Fenofibrate can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Fenofibrate can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Fenofibrate.]
[D07XB03, fluprednidene, The metabolism of Fenofibrate can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V08CA05, mangafodipir, Fenofibrate may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Fenofibrate.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Fenofibrate.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Fenofibrate.]
[L01FX15, belantamab mafodotin, Fenofibrate may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[L04AC19, satralizumab, The serum concentration of Fenofibrate can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Fenofibrate.]
[L01EX23, pralsetinib, Pralsetinib may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, Chlorpromazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Chlorzoxazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C10AC01, cholestyramine resin, Cholestyramine can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N02BA03, choline salicylate, Fenofibrate may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, The metabolism of Etodolac can be decreased when combined with Fenofibrate.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of adverse effects can be increased when Fenofibrate is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Fenofibrate can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The serum concentration of Lonafarnib can be increased when it is combined with Fenofibrate.]
[M01AX25, chondroitin sulfates, Fenofibrate may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Fenofibrate can be increased when it is combined with Abametapir.]
[N03AX10, felbamate, The metabolism of Fenofibrate can be increased when combined with Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R03BA03, flunisolide, The metabolism of Fenofibrate can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Fenofibrate can be increased when combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, Fluorescein may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02BG07, flupirtine, Fenofibrate may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Fenofibrate.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin human.]
[A02BA01, cimetidine, Cimetidine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Fenofibrate.]
[L01XX73, sotorasib, The serum concentration of Fenofibrate can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Fenofibrate.]
[S03AA07, ciprofloxacin, The metabolism of Fenofibrate can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Fenofibrate may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The risk or severity of QTc prolongation can be increased when Fenofibrate is combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The metabolism of Fenofibrate can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Fenofibrate.]
[V09AB03, ioflupane I-123, Fenofibrate may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Fenofibrate may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Fenofibrate may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L04AA59, avacopan, The metabolism of Fenofibrate can be decreased when combined with Avacopan.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Fenofibrate.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Gliquidone.]
[N06AX25, St. John's wort extract, The metabolism of Fenofibrate can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Fenofibrate can be decreased when combined with Asciminib.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Fenofibrate.]
[J04BA01, clofazimine, The metabolism of Fenofibrate can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The risk or severity of adverse effects can be increased when Clofibrate is combined with Fenofibrate.]
[B06AX04, mitapivat, The metabolism of Fenofibrate can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, Levobupivacaine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EJ03, pacritinib, The metabolism of Fenofibrate can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Fenofibrate.]
[N03AE01, clonazepam, Fenofibrate may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Fenofibrate.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Fenofibrate.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A05BA08, glycyrrhizic acid, Fenofibrate may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Fenofibrate.]
[N05AH02, clozapine, The metabolism of Fenofibrate can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Fenofibrate may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Fenofibrate can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Fenofibrate can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Colchicine.]
[C10AC02, colestipol, Colestipol can cause a decrease in the absorption of Fenofibrate resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01XB01, colistin, Fenofibrate may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Leflunomide.]
[A04AA03, tropisetron, Fenofibrate may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Fenofibrate.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin glargine.]
[J01FA15, telithromycin, The metabolism of Fenofibrate can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AB14, valganciclovir, Fenofibrate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Fenofibrate may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Fenofibrate may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Fenofibrate may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Fenofibrate may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Fenofibrate may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Fenofibrate.]
[N02CC05, almotriptan, Almotriptan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Fenofibrate.]
[J02AC02, itraconazole, The metabolism of Fenofibrate can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05BA10, ketazolam, The metabolism of Fenofibrate can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EA01, imatinib, Imatinib may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J02AC04, posaconazole, The metabolism of Fenofibrate can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Fenofibrate.]
[N03AX09, lamotrigine, Lamotrigine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nafarelin is combined with Fenofibrate.]
[S01BA03, cortisone, The metabolism of Fenofibrate can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Fenofibrate may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R06AX13, loratadine, Loratadine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Fenofibrate may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Fenofibrate can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Mebeverine.]
[H02AB15, meprednisone, The metabolism of Fenofibrate can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Fenofibrate can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Fenofibrate may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Fenofibrate can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Fenofibrate.]
[S01XA18, cyclosporine, The risk or severity of renal failure can be increased when Cyclosporine is combined with Fenofibrate.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Fenofibrate.]
[N06BA07, modafinil, The metabolism of Fenofibrate can be increased when combined with Modafinil.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Fenofibrate can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cytarabine is combined with Fenofibrate.]
[M01AH05, etoricoxib, The metabolism of Fenofibrate can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, Dacarbazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Fenofibrate can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Fenofibrate.]
[L01DB02, daunorubicin, Daunorubicin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Fenofibrate.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Fenofibrate.]
[N07BB05, nalmefene, Fenofibrate may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Fenofibrate.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Fenofibrate can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Fenofibrate may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Nilutamide can be decreased when combined with Fenofibrate.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Fenofibrate.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Fenofibrate can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V04CH02, indigo carmine, Fenofibrate may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Fenofibrate can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Fenofibrate can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Fenofibrate can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Fenofibrate can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, Amphetamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Fenofibrate.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Fenofibrate.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Fenofibrate.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Fenofibrate.]
[C01DA05, pentaerythritol tetranitrate, Fenofibrate may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Fenofibrate may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Fenofibrate.]
[R05DA08, pholcodine, Fenofibrate may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, Diclofenac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01CF01, dicloxacillin, The metabolism of Fenofibrate can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Fenofibrate.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Fenofibrate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Fenofibrate.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, Diethylstilbestrol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C08CA03, isradipine, The metabolism of Fenofibrate can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Fenofibrate can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The metabolism of Fenofibrate can be decreased when combined with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Fenofibrate.]
[C01AA05, digoxin, Fenofibrate may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C10AX09, ezetimibe, The serum concentration of Ezetimibe can be increased when it is combined with Fenofibrate.]
[C04AE04, dihydroergocristine, Fenofibrate may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Fenofibrate.]
[N02AA03, hydromorphone, The metabolism of Hydromorphone can be decreased when combined with Fenofibrate.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Fenofibrate can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Fenofibrate.]
[H03BC01, potassium perchlorate, Fenofibrate may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C08DB01, diltiazem, The metabolism of Fenofibrate can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Fenofibrate may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Fenofibrate can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C05CA03, diosmin, The metabolism of Fenofibrate can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Fenofibrate.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Fenofibrate.]
[B01AC07, dipyridamole, Dipyridamole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A03FA02, cisapride, The metabolism of Fenofibrate can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Fenofibrate.]
[S01AX06, resorcinol, Fenofibrate may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P03AA04, disulfiram, Disulfiram may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S02AA12, rifamycin SV, The metabolism of Fenofibrate can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Fenofibrate can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Fenofibrate may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, Ropivacaine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Fenofibrate.]
[A04AD12, aprepitant, The metabolism of Fenofibrate can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Fenofibrate.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Fenofibrate.]
[J05AE07, fosamprenavir, The metabolism of Fenofibrate can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Fenofibrate.]
[C01EB18, ranolazine, Ranolazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Salmeterol is combined with Fenofibrate.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fenofibrate.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Fenofibrate.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Fenofibrate.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Fenofibrate.]
[N01AB08, sevoflurane, The metabolism of Sevoflurane can be decreased when combined with Fenofibrate.]
[A08AA10, sibutramine, Fenofibrate may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Fenofibrate may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[H01AA01, corticotropin, The metabolism of Fenofibrate can be increased when combined with Corticotropin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AC02, tenoxicam, The metabolism of Tenoxicam can be decreased when combined with Fenofibrate.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Terbinafine is combined with Fenofibrate.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Emetine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Fenofibrate.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Fenofibrate.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AG03, toloxatone, Fenofibrate may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Atomoxetine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N03AX11, topiramate, The metabolism of Fenofibrate can be increased when combined with Topiramate.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Fenofibrate may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Fenofibrate.]
[N06AX16, venlafaxine, Venlafaxine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C08CA12, mepirodipine, The metabolism of Fenofibrate can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Fenofibrate can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Fenofibrate.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Fenofibrate.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Iloprost.]
[N02CA02, ergotamine, The metabolism of Fenofibrate can be decreased when combined with Ergotamine.]
[N03AG01, valproic acid, The metabolism of Fenofibrate can be decreased when combined with Valproic acid.]
[L03AX05, pidotimod, Fenofibrate may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, Erythromycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CD04, estazolam, Fenofibrate may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Fenofibrate.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Fenofibrate.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Fenofibrate can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Fenofibrate can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Fluvastatin.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, Ethinylestradiol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01BD05, ibutilide, Ibutilide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Fenofibrate.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Fenofibrate.]
[L04AD02, tacrolimus, Tacrolimus may increase the nephrotoxic activities of Fenofibrate.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Fenofibrate.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Fenofibrate.]
[R06AX12, terfenadine, The metabolism of Fenofibrate can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Fenofibrate may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Fenofibrate.]
[N06AB08, fluvoxamine, The metabolism of Fenofibrate can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Fenofibrate.]
[M01CB01, gold sodium thiomalate, Fenofibrate may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Fenofibrate.]
[D11AX24, deoxycholic acid, The therapeutic efficacy of Deoxycholic acid can be decreased when used in combination with Fenofibrate.]
[B05AA05, dextran, Fenofibrate may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Fenofibrate can be decreased when combined with Albendazole.]
[C08CA02, felodipine, Felodipine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02AB03, fentanyl, Fentanyl may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01BB06, clofarabine, Clofarabine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Fenofibrate.]
[N07AX03, cevimeline, Cevimeline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G04BD02, flavoxate, Fenofibrate may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01CF05, floxacillin, Flucloxacillin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Fenofibrate can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Fenofibrate may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Fenofibrate may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Fenofibrate.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Fenofibrate.]
[D07AC08, fluocinonide, The metabolism of Fenofibrate can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Fenofibrate can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ethanol is combined with Fenofibrate.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Fenofibrate.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Fenofibrate.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01BC04, flurbiprofen, The metabolism of Flurbiprofen can be decreased when combined with Fenofibrate.]
[L02BB01, flutamide, Flutamide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fenofibrate.]
[J05AE10, darunavir, The metabolism of Fenofibrate can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Alendronic acid is combined with Fenofibrate.]
[N05CF04, eszopiclone, Eszopiclone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Fenofibrate.]
[N03AA04, barbexaclone, The metabolism of Fenofibrate can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The risk or severity of adverse effects can be increased when Fenofibrate is combined with Gemfibrozil.]
[J01XA03, telavancin, Fenofibrate may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Fenofibrate.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Fenofibrate.]
[J05AG04, etravirine, The metabolism of Fenofibrate can be increased when combined with Etravirine.]
[N03AD03, methsuximide, The metabolism of Methsuximide can be decreased when combined with Fenofibrate.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Fenofibrate.]
[A10BB01, glyburide, Glyburide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BB09, gliclazide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Gliclazide.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glipizide.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Fenofibrate.]
[C02CA04, doxazosin, The metabolism of Fenofibrate can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Fenofibrate.]
[M01CB04, aurothioglucose, Fenofibrate may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Fenofibrate may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Fenofibrate.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[D01BA01, griseofulvin, The metabolism of Fenofibrate can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Fenofibrate may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Fenofibrate.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Fenofibrate.]
[N01AB01, halothane, The metabolism of Halothane can be decreased when combined with Fenofibrate.]
[N05AH04, quetiapine, Fenofibrate may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Fenofibrate may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Fenofibrate.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C09CA01, losartan, Losartan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Fenofibrate.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CA16, hexobarbital, The metabolism of Hexobarbital can be decreased when combined with Fenofibrate.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Fenofibrate.]
[C08CA10, nilvadipine, The metabolism of Fenofibrate can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Fenofibrate can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The therapeutic efficacy of Fenofibrate can be decreased when used in combination with Hydrochlorothiazide.]
[S02BA01, hydrocortisone, The metabolism of Fenofibrate can be increased when combined with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Fenofibrate can be increased when combined with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Fenofibrate may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G04BD06, propiverine, Fenofibrate may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Fenofibrate.]
[B05AA07, hetastarch, Fenofibrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[J04AB04, rifabutin, The metabolism of Fenofibrate can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Risedronic acid is combined with Fenofibrate.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Fenofibrate.]
[B05XA08, sodium acetate, Fenofibrate may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Fenofibrate.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Fenofibrate.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Fenofibrate.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Fenofibrate.]
[R01AD07, tixocortol, Fenofibrate may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, Topotecan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A11HA07, inositol, Fenofibrate may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Fenofibrate can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Fenofibrate may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, Fenofibrate may decrease the excretion rate of Sitagliptin which could result in a higher serum level.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Fenofibrate.]
[C10AA06, cerivastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Cerivastatin.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Stavudine is combined with Fenofibrate.]
[J04AC01, isoniazid, The metabolism of Fenofibrate can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Fenofibrate may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Isotretinoin is combined with Fenofibrate.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Fenofibrate.]
[S01AA24, kanamycin, Fenofibrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate.]
[L04AC07, tocilizumab, The metabolism of Fenofibrate can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Fenofibrate.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Fenofibrate.]
[J02AB02, ketoconazole, The metabolism of Fenofibrate can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Fenofibrate can be decreased when combined with Levoketoconazole.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[V03AC03, deferasirox, The metabolism of Fenofibrate can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fenofibrate can be increased when combined with Abatacept.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Fenofibrate.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A06AX03, lubiprostone, Fenofibrate may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Fenofibrate.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A05AA02, ursodiol, The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Fenofibrate.]
[S01AA21, amikacin, Fenofibrate may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Fenofibrate can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[A07DA03, loperamide, The metabolism of Loperamide can be decreased when combined with Fenofibrate.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Fenofibrate can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Fenofibrate.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Fenofibrate.]
[B05XA11, magnesium chloride, Fenofibrate may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Fenofibrate may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Fenofibrate may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Fenofibrate can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, Maprotiline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Fenofibrate.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Fenofibrate may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Fenofibrate can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Fenofibrate.]
[N03AA01, mephobarbital, The metabolism of Fenofibrate can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, Mepivacaine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G04BX16, tiopronin, Fenofibrate may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[L02BG01, aminoglutethimide, The metabolism of Fenofibrate can be increased when combined with Aminoglutethimide.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Fenofibrate may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[H01CB03, lanreotide, The metabolism of Fenofibrate can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Fenofibrate can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, Fenofibrate may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lamivudine is combined with Fenofibrate.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Fenofibrate can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Fenofibrate may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Fenofibrate.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Fenofibrate.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methyldopa is combined with Fenofibrate.]
[V04CG05, methylene blue, The metabolism of Fenofibrate can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Fenofibrate can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Fenofibrate.]
[H02AB04, methylprednisolone, The metabolism of Fenofibrate can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Fenofibrate can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, Fenofibrate may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[N02CA04, methysergide, The metabolism of Fenofibrate can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Metoclopramide.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Metoprolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Fenofibrate can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Fenofibrate can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Fenofibrate can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Fenofibrate.]
[N05CD08, midazolam, The metabolism of Fenofibrate can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, Mifepristone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Fenofibrate.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Minocycline is combined with Fenofibrate.]
[J01FA11, miocamycin, The metabolism of Fenofibrate can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Fenofibrate can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Fenofibrate can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Fenofibrate can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fenofibrate.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Fenofibrate.]
[A04AA05, palonosetron, Palonosetron may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Fenofibrate can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Fenofibrate can be decreased when combined with Eltrombopag.]
[G04BA01, ammonium chloride, Fenofibrate may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Fenofibrate.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CA02, amobarbital, The metabolism of Fenofibrate can be increased when combined with Amobarbital.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Raltegravir.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Fenofibrate.]
[G03XC01, raloxifene, The metabolism of Fenofibrate can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Fenofibrate can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Fenofibrate may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Fenofibrate may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The metabolism of Fenofibrate can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Fenofibrate can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Naltrexone is combined with Fenofibrate.]
[L04AC03, anakinra, The metabolism of Fenofibrate can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Amphetamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M02AA12, naproxen, Naproxen may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10BG01, troglitazone, Troglitazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Fenofibrate.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Fenofibrate.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Letrozole is combined with Fenofibrate.]
[S03AA01, neomycin, Fenofibrate may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, Repaglinide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Amphotericin B is combined with Fenofibrate.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L03AX16, plerixafor, Fenofibrate may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Fenofibrate may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Fenofibrate can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Telmisartan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01CE01, inamrinone, Fenofibrate may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Niacin is combined with Fenofibrate.]
[C08CA04, nicardipine, The metabolism of Fenofibrate can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Fenofibrate.]
[N07BA01, nicotine, The metabolism of Nicotine can be decreased when combined with Fenofibrate.]
[C08CA05, nifedipine, Fenofibrate may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The metabolism of Fenofibrate can be decreased when combined with Niflumic acid.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C08CA08, nitrendipine, Fenofibrate may decrease the excretion rate of Nitrendipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G03DC02, norethindrone, The metabolism of Fenofibrate can be decreased when combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Norfloxacin.]
[C02KX01, bosentan, Bosentan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Fenofibrate.]
[R05DA07, noscapine, The metabolism of Fenofibrate can be decreased when combined with Noscapine.]
[H01CB02, octreotide, The metabolism of Fenofibrate can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, Fenofibrate may decrease the excretion rate of Ofloxacin which could result in a higher serum level.]
[J01FA05, oleandomycin, The metabolism of Fenofibrate can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Fenofibrate can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Fenofibrate can be increased when combined with Omeprazole.]
[N02AA02, opium, Fenofibrate may decrease the excretion rate of Opium which could result in a higher serum level.]
[G04CA02, tamsulosin, Tamsulosin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J04AB30, capreomycin, Fenofibrate may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The metabolism of Fenofibrate can be increased when combined with Paramethasone.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[G04BD11, fesoterodine, Fenofibrate may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Fenofibrate may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Penicillamine is combined with Fenofibrate.]
[J01CE09, penicillin G procaine, Fenofibrate may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Fenofibrate can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Fenofibrate may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Pentoxifylline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Fenofibrate.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Fenofibrate is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Fenofibrate.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Fenofibrate.]
[V03AB36, phentolamine, Phentolamine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[M02AA01, phenylbutazone, The metabolism of Fenofibrate can be increased when combined with Phenylbutazone.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Fenofibrate.]
[N03AB02, phenytoin, The metabolism of Fenofibrate can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Fenofibrate can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Fenofibrate may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Fenofibrate.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C08CX01, mibefradil, The metabolism of Fenofibrate can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Fenofibrate.]
[C07AA03, pindolol, Pindolol may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Fenofibrate can be decreased when combined with Saquinavir.]
[N06BX03, piracetam, Fenofibrate may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Eprosartan is combined with Fenofibrate.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Fenofibrate.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AG02, delavirdine, The metabolism of Fenofibrate can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Fenofibrate can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Fenofibrate.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Fenofibrate.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Fenofibrate.]
[L04AC08, canakinumab, The metabolism of Fenofibrate can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Fenofibrate can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Fenofibrate may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Potassium chloride may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Insulin lispro.]
[C10AA08, pitavastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibrate is combined with Pitavastatin.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fenofibrate.]
[S03BA02, prednisolone, The metabolism of Fenofibrate can be increased when combined with Prednisolone.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Fenofibrate can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Fenofibrate can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Fenofibrate can be increased when combined with Probenecid.]
[C01BA02, procainamide, Fenofibrate may decrease the excretion rate of Procainamide which could result in a higher serum level.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Procarbazine.]
[G03DA04, progesterone, Progesterone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Fenofibrate.]
[R06AD02, promethazine, Fenofibrate may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Fenofibrate.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propofol is combined with Fenofibrate.]
[N02AC04, propoxyphene, The metabolism of Fenofibrate can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Fenofibrate.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Fenofibrate.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[B01AC09, epoprostenol, Fenofibrate may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Fenofibrate.]
[N07XX07, dalfampridine, Fenofibrate may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Fenofibrate may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[C01BA01, quinidine, Fenofibrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The metabolism of Fenofibrate can be increased when combined with Quinine.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ranitidine is combined with Fenofibrate.]
[C02AA02, reserpine, Reserpine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Fenofibrate can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Fenofibrate can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
[S01BC08, salicylic acid, The metabolism of Salicylic acid can be decreased when combined with Fenofibrate.]
[N05CA06, secobarbital, The metabolism of Fenofibrate can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Fenofibrate.]
[J01GB08, sisomicin, Fenofibrate may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Fenofibrate may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[H01CB01, somatostatin, The metabolism of Fenofibrate can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Fenofibrate may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Fenofibrate.]
[C03DA01, spironolactone, Spironolactone may decrease the excretion rate of Fenofibrate which could result in a higher serum level.]
